Pulmonary Sarcoidosis Investigational Medication

Trial Objective

Pulmonary Sarcoidosis Investigational MedicationThis research study evaluates an investigational medication called Acthar® Gel (Acthar) as a potential treatment of pulmonary sarcoidosis.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

People with biopsy-confirmed sarcoidosis for more than a year.

Age: 18-90    Gender: Any Gender


Estimated Time Commitment

Participants in the study inject the medication twice a week at home and have appointments every 4 weeks.

Study participants will need to fast prior to their visits. Visit lengths will vary.



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Cindy Wainscoat
303.398.1259

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Mallinckrodt Pharmaceuticals

Principal Investigators


Request More Information

Complete this form to learn more about this study and see if you qualify.


*
*
*
*